We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,742 results
  1. Clinical features, treatment, and outcome of pembrolizumab induced cholangitis

    Pembrolizumab induced hepatitis has received increasing attention, while pembrolizumab induced cholangitis is poorly understood. This study...

    Weilun Fang, Wei Sun, ... Chunjiang Wang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 15 May 2024
  2. Hematologic traits and primary biliary cholangitis: a Mendelian randomization study

    Hematologic abnormalities was observationally associated with the susceptibility of primary biliary cholangitis (PBC). However, the conclusion is...

    Bin Ke, Chunyu Li, Huifang Shang in Journal of Human Genetics
    Article 03 April 2023
  3. Clinical and microbiological characteristics of reflux cholangitis following bilio-enteric anastomosis

    Twenty-five patients with reflux cholangitis (RC) defined as acute cholangitis (AC) with normal abdominal imaging occurring > 3 months after...

    Audrey Le Bot, Aurélien Sokal, ... Victoire de Lastours in European Journal of Clinical Microbiology & Infectious Diseases
    Article 18 July 2022
  4. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis

    Primary Sclerosing Cholangitis (PSC) is a progressive cholestatic liver disease with no licensed therapies. Previous Genome Wide Association Studies...

    Jessica Leighton, David E. J. Jones, ... Heather J. Cordell in BMC Medical Genomics
    Article Open access 11 June 2024
  5. Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression

    The interferon (IFN) signaling pathways are major immunological checkpoints with clinical significance in the pathogenesis of autoimmunity. We have...

    Tihong Shao, Patrick S. C. Leung, ... M. Eric Gershwin in Cellular & Molecular Immunology
    Article Open access 30 August 2022
  6. The Experience of Using Multipotent Mesenchymal Stromal Cells in the Treatment of Severe Recurrent Cholangitis in Children with Biliary Atresia after Kasai Surgery

    This article describes the experience of application of multipotent mesenchymal stromal cells in the complex therapy of severe recurrent cholangitis...

    A. V. Degtyareva, М. H. Isaeva, ... G. T. Sukhikh in Bulletin of Experimental Biology and Medicine
    Article 28 November 2022
  7. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis

    The close relationship between primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) provides a good opportunity to comprehend...

    You Sun Kim, Edward H. Hurley, ... Sung** Ko in Experimental & Molecular Medicine
    Article Open access 18 July 2023
  8. An Assessment of the Serum Activity of ADH and ALDH in Patients with Primary Biliary Cholangitis

    Primary biliary cholangitis (PBC; previously known as primary biliary cirrhosis) is a chronic inflammation-induced cholestatic process in the liver....

    Blanka Wolszczak-Biedrzycka, Anna Bieńkowska, ... Wojciech Jelski in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 28 December 2022
  9. ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis

    Background

    Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, with unclear pathogenesis. Although immune disorders,...

    Jian Zhang, Huiwen Wang, ... Shifang Peng in Human Genomics
    Article Open access 21 September 2023
  10. Specificities of acute cholangitis in patients with cancer: a retrospective comparative study of 130 episodes

    Pancreatic and biliary duct cancers are increasing causes of acute cholangitis (AC). We retrospectively characterize 81 cancer-associated cholangitis...

    Aurélien Sokal, Sylvain Chawki, ... Victoire de Lastours in European Journal of Clinical Microbiology & Infectious Diseases
    Article 20 August 2021
  11. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis

    Primary sclerosing cholangitis (PSC) is an immune-mediated disease of the bile ducts that co-occurs with inflammatory bowel disease (IBD) in almost...

    Dustin G. Shaw, Raúl Aguirre-Gamboa, ... Bana Jabri in Nature Medicine
    Article Open access 15 June 2023
  12. Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis

    Chronic liver diseases, e.g., cholestasis, are negatively impacted by inflammation, which further aggravates liver injury. Pharmacotherapy targeting...

    Gina M. Gallucci, Bader Alsuwayt, ... Nisanne S. Ghonem in Inflammation
    Article 15 July 2022
  13. Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome

    Background

    Primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) variant syndrome (VS) exhibit a complex overlap of AIH features with PBC,...

    Fan Yang, Leyu Zhou, ... Li Yang in Journal of Translational Medicine
    Article Open access 29 February 2024
  14. A case report and review of acute cholangitis with septic shock induced by Edwardsiella tarda

    Background

    Edwardsiella tarda ( E. tarda ) is a gram-negative facultative anaerobic bacterium. Gastroenteritis is the most common manifestation of E....

    Article Open access 04 July 2022
  15. Microorganisms in Pathogenesis and Management of Primary Biliary Cholangitis (with Focus on Molecular Mimicry)

    Primary biliary cholangitis (PBC) has been considered an enigmatic autoimmune liver disease. The immunopathogenesis of PBC has been considered a...
    Eirini I. Rigopoulou, Andreas L. Koutsoumpas, Dimitrios P. Bogdanos in Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
    Chapter 2022
  16. Microorganisms in the Pathogenesis and Management of Primary Biliary Cholangitis (with Focus on SARS-CoV-2 & Gut Microbiota)

    Primary biliary cholangitis is a chronic cholestatic liver disease characterized by a selective and progressive destruction of interlobular bile...
    Matei-Alexandru Cozma, Camelia-Cristina Diaconu in Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
    Chapter 2022
  17. Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodes

    With rising antibiotic resistance, alternatives to carbapenems are needed for acute cholangitis (AC). Temocillin reaches high biliary concentrations...

    Sylvain Chawki, Aurélien Sokal, ... Victoire de Lastours in European Journal of Clinical Microbiology & Infectious Diseases
    Article 20 February 2021
  18. Primary Biliary Cholangitis

    Primary biliary cholangitis (PBC), formally named primary biliary cirrhosis until 2016, is a chronic cholestatic liver disease that can potentially...
    Atsushi Tanaka, Patrick S. C. Leung, ... M. Eric Gershwin in Liver Immunology
    Chapter 2020
  19. Primary Sclerosing Cholangitis

    Primary sclerosing cholangitis (PSC) is a chronic, fibro-inflammatory disease of the intrahepatic and extrahepatic bile ducts and is strongly...
    Christopher L. Bowlus in Liver Immunology
    Chapter 2020
Did you find what you were looking for? Share feedback.